15 (for monocentric Phase I trials)
(up to 90 days if the Belgian Biosafety Advisory Council has to be asked for advice)
No time limit
The order of submission to the EC and CA is not defined. The trial cannot start until both instances have given a positive reaction.
In case of questions to the applicant: One clock-stop of maximum one month for supplementary information is possible